Position of oral cephalosporins and its fixed-dose combinations in the guideline recommendations for the management of community-acquired infections

Authors

DOI:

https://doi.org/10.3126/ajms.v14i9.54674

Keywords:

Anti-microbial resistance, Cephalosporins, Community-acquired infections, Fixed-dose combination, India

Abstract

Community-acquired infections (CAIs) represent a major burden for health-care system. This directly aids the emergence of antibiotic-resistant organisms. India is not immune to it. This review assessed the current guideline recommendations for the usage of oral cephalosporins in the management of common CAIs. The researchers conducted iterative searches in PubMed, SCOPUS, and Google Scholar for published articles using various keywords. The search was conducted in November 2022 and considered articles published till date. Different CAIs are caused by similar organisms, susceptible to first-line antibiotics such as penicillin and cephalosporins. Most of the guidelines recommend the use of oral cephalosporins for the management of the commonly prevalent CAIs. These antibiotics however should be used as a monotherapy and not as fixed-dose combinations (FDCs), as FDCs with oral cephalosporins lack scientific basis and may be detrimental. For burden of CAIs intensified by anti-microbial resistance, guidelines are useful for the management of CAIs to educate the prescribers and preserve currently available antibiotics.

Downloads

Download data is not yet available.
Abstract
99
PDF
338

Downloads

Published

2023-09-01

How to Cite

Mala Kaneria, Ilambarathi M, Singh, V., Varun N, Rashmi Hegde, Praveen Kamble, & Krunal Dalal. (2023). Position of oral cephalosporins and its fixed-dose combinations in the guideline recommendations for the management of community-acquired infections. Asian Journal of Medical Sciences, 14(9), 281–291. https://doi.org/10.3126/ajms.v14i9.54674

Issue

Vol. 14 No. 9 (2023)

Section

Review Articles

License

Copyright (c) 2023 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).